Skip to main content
Premium Trial:

Request an Annual Quote

Luminex Posts Revenue Boost, Narrowed Losses for Q1 2003

NEW YORK, April 21 - Luminex today reported an increase in revenues accompanied by decreased losses for the quarter ended March 31, 2003.


Revenue for the first quarter of 2003 was $5.1 million, compared with $2.3 million in the year-ago period. The company broke this down to $3.0 million from the sale of 131 Luminex systems, $1.2 million from the sale of consumables, $219,000 in royalties, and $664,000 of other revenues.


Luminex posted a net loss for the first quarter of $906,000, or $0.03 per share, compared with $6.6 million, or $0.23 per share, in the first quarter of 2002. The company said the improvement in net losses was partly due to $1.8 million received in the settlement of a lawsuit with its prior patent counsel. Excluding this amount, Luminex said its net losses for the quarter would have been $2.7 million.


The company also slashed its operating expenses. R&D expenses for the first quarter of 2003 were $831,000 compared to $2.0 million in the year-ago period; and selling, general, and administrative expenses were $3.5 million in Q1 03 compared to $5.1 million in Q1 02.


Full details of the company's earnings report are available here.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.